Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Assets
Current assets:
Cash and cash equivalents
Cash, cash equivalents and restricted cash
Accounts receivable, net
Income tax receivable
Prepaid expenses and other current assets
Current assets of disposal group held for sale
Total current assets
Property and equipment, net
Right-of-use assets
Other assets
Goodwill
Total assets
Liabilities and Stockholders' Deficit
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Warrant liabilities
Convertible notes, net of unamortized discount of $73 as of September 30, 2024
Senior secured convertible notes, net of unamortized discount of $30,855 as of September 30, 2024 (Note 6)
Related party senior secured convertible notes, net of unamortized discount of $12,581 and $0 as of September 30, 2024 and December 31, 2023, respectively (including future interest of $14,242 and $1,976 as of September 30, 2024 and December 31, 2023, respectively) (Note 6)
Derivative liabilities
Current portion of capital lease obligations
Total current liabilities
Convertible notes, net of unamortized discount of $259 as of December 31, 2023
Embedded derivative liability
Senior secured convertible notes, net of unamortized discount of $11,066 as of December 31, 2023 (Note 6)
Related party senior secured convertible notes, net of unamortized discount of $7,951 as of December 31, 2023 (including future interest of $9,747) (Note 6)
Derivative liabilities
Other long-term liabilities
Total liabilities
Stockholders' deficit:
Common stock - $0.001 par value; 300,000,000 and 164,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; 3,778,030 and 2,857,484 shares issued as of September 30, 2024 and December 31, 2023, respectively; 3,677,726 and 2,783,748 shares outstanding as of September 30, 2024 and December 31, 2023, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock - at cost; 100,304 and 73,736 shares as of September 30, 2024 and December 31, 2023, respectively
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support